series-c-plus
Stage
2
Investors
About
Procyrion develops Aortix™, a percutaneous mechanical circulatory support device aimed at improving aortic flow and renal perfusion to treat heart failure patients with cardiorenal syndrome, currently in clinical trial stages.
Explore Procyrion's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.